SCHEMBL5345756

SCHEMBL5345756

Cc1c(Cl)cccc1S(=O)(=O)Nc1ccc2occ(C)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.52
HIF1A Q16665 2/20 0.48
EDNRB P24530 2/20 0.47
EDNRA P25101 2/20 0.47
ALDH1A1 P00352 1/20 0.44
TP53 P04637 3/20 0.43
MAPT P10636 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SLC22A12 Q96S37 2/20 0.43
GSPT1 P15170 1/20 0.43
DDB1 Q16531 1/20 0.43
CRBN Q96SW2 1/20 0.43
SLC40A1 Q9NP59 1/20 0.42
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
PTPN2 P17706 2/20 0.42
PTPN1 P18031 2/20 0.42
PTPN5 P54829 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5344480 0.80 EDNRA (0.61) HSD11B1HIF1AEDNRBEDNRATP53
SCHEMBL5337088 0.77 HSD11B1 (0.50) HSD11B1HIF1AEDNRBEDNRAALDH1A1
SCHEMBL5345572 0.77 ALDH1A1 (0.64) EDNRBEDNRAALDH1A1MEN1KMT2A
SCHEMBL5340650 0.76 HSD11B1 (0.46) HSD11B1HIF1AEDNRBEDNRAALDH1A1
SCHEMBL618236 0.75 PTPN1 (0.59) HSD11B1EDNRBEDNRAPTPN2PTPN1
SCHEMBL5339534 0.75 EDNRA (0.52) HSD11B1HIF1AEDNRBEDNRAALDH1A1
SCHEMBL7578851 0.75 HSD11B1 (0.58) HSD11B1EDNRBEDNRAMEN1KMT2A
SCHEMBL618067 0.75 BRD4 (0.56) HSD11B1EDNRBEDNRAMAPTMEN1
SCHEMBL3768958 0.73 HSD11B1 (0.60) HSD11B1EDNRBEDNRAALDH1A1MAPT
SCHEMBL12640414 0.73 MAPT (0.64) ALDH1A1TP53MAPTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 HSD11B1 6/4885HIF1A 3282/4885EDNRB 396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.